This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Pierrel Past Earnings Performance
Past criteria checks 4/6
Pierrel has been growing earnings at an average annual rate of 7.3%, while the Pharmaceuticals industry saw earnings growing at 13.1% annually. Revenues have been growing at an average rate of 4.4% per year. Pierrel's return on equity is 12.1%, and it has net margins of 11.5%.
How Pierrel makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
BIT:PRL Revenue, expenses and earnings (EUR Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
30 Jun 23
27
3
7
0
31 Mar 23
25
1
7
0
31 Dec 22
24
1
7
0
30 Sep 22
25
1
7
0
30 Jun 22
24
2
7
0
31 Mar 22
23
3
7
0
31 Dec 21
24
3
7
0
30 Sep 21
21
3
6
0
30 Jun 21
19
1
6
0
31 Mar 21
21
3
6
0
31 Dec 20
18
2
6
0
30 Sep 20
20
3
6
0
30 Jun 20
23
4
6
0
31 Mar 20
21
2
6
0
31 Dec 19
22
2
6
0
30 Sep 19
22
1
6
0
30 Jun 19
21
1
6
0
31 Mar 19
21
1
6
0
31 Dec 18
20
1
6
0
30 Sep 18
21
2
6
0
30 Jun 18
20
2
6
0
31 Mar 18
19
0
5
0
31 Dec 17
17
-3
5
0
30 Sep 17
15
-8
5
0
30 Jun 17
14
-9
5
0
31 Mar 17
14
-8
5
0
31 Dec 16
15
-6
5
0
30 Sep 16
14
-2
6
0
30 Jun 16
14
-1
6
0
31 Mar 16
15
0
6
0
31 Dec 15
16
0
6
0
30 Sep 15
5
10
-2
0
30 Jun 15
8
6
0
0
31 Mar 15
13
0
3
0
31 Dec 14
15
-2
6
0
30 Sep 14
30
-16
17
0
30 Jun 14
29
-16
17
0
31 Mar 14
29
-12
17
0
31 Dec 13
30
-13
17
0
30 Sep 13
30
-14
18
0
30 Jun 13
36
-12
18
0
31 Mar 13
40
-13
19
0
Quality Earnings: PRL has a large one-off gain of €741.2K impacting its last 12 months of financial results to 30th June, 2023.
Growing Profit Margin: PRL's current net profit margins (11.5%) are higher than last year (7.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PRL has become profitable over the past 5 years, growing earnings by 7.3% per year.
Accelerating Growth: PRL's earnings growth over the past year (75.3%) exceeds its 5-year average (7.3% per year).
Earnings vs Industry: PRL earnings growth over the past year (75.3%) exceeded the Pharmaceuticals industry 3.7%.
Return on Equity
High ROE: PRL's Return on Equity (12.1%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2024/01/24 15:53
End of Day Share Price
2024/01/24 00:00
Earnings
2023/06/30
Annual Earnings
2022/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Pierrel S.p.A. is covered by 2 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.